Skip to main content
. Author manuscript; available in PMC: 2018 Jul 9.
Published in final edited form as: Mol Carcinog. 2017 Jan 2;56(4):1335–1343. doi: 10.1002/mc.22595

Figure 2.

Figure 2.

Kaplan-Meier estimates for the DFS of patients according to the combined risk genotypes of the 5 polymorphisms of E2F2 among all patients and those with human papillomavirus (HPV)–positive SCCOP. The high-risk group included patients with 2–5 risk genotypes, and the low-risk group included patients with 0–1 risk genotype.